Zylox-Tonbridge Medical Technology. 

HK$11.24
0
-HK$0.26-2.26% 今日

統計情報

日高
-
日 低
-
52W高
-
52W Low
-
出来高
-
平均出来高
-
時価総額
4.17B
PER(株価収益率)
-
配当利回り
-
配当金
-

今後のイベント

収益

19Aug予想値
Q2 2023
Q4 2023
Q1 2024
Q2 2024
0.23
0.56
0.89
1.23
予想EPS
利用不可
実績EPS
0.22770169240000002

他の人はこんな銘柄もフォローしています

このリストは、Stock Eventsで2190.HKをフォローしている人のウォッチリストを元に作成されています。投資推奨ではありません。

競合他社

このリストは、最近の市場の出来事に基づいた分析です。投資の勧めではありません。

概要

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, stenosis, carotid artery, and vascular access device. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Show more...
CEO
Dr. Zhong Zhao
従業員数
594
国名
Hong Kong
ISIN
CNE100004JD2

掲載内容